Biosketch / Results /

Yongzhao Shao

Professor, Department of Population Health
Professor, Department of Environmental Medicine


Contact Info

212/263-0324
Yongzhao.Shao@nyumc.org


De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival
Cymerman, Rachel M; Shao, Yongzhao; Wang, Kun; Zhang, Yilong; Murzaku, Era C; Penn, Lauren A; Osman, Iman; Polsky, David. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. Journal of the National Cancer Institute. 2016 May 27;108(10):?-? (2115202)

Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates
Sun, Xiaoqiang; Bao, Jiguang; Shao, Yongzhao. Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates. Scientific reports. 2016 Mar 1;6:22498-22498 (2006282)

Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors
Chang, Gregory A; Tadepalli, Jyothirmayee S; Fleming, Nathaniel H; Lui, Kevin; Shao, Yongzhao; Darvishian, Farbod; Pavlick, Anna; Berman, Russell; Shapiro, Richard; Osman, Iman; Polsky, David. Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors [Meeting Abstract]. Cancer research. 2015 JUL 15;75:?-? (2029702)

Sensitivity of plasma BRAF and NRAS cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
Chang, Gregory A; Tadepalli, Jyothirmayee S; Shao, Yongzhao; Zhang, Yilong; Weiss, Sarah; Robinson, Eric; Spittle, Cindy; Furtado, Manohar; Shelton, Dawne N; Karlin-Neumann, George; Pavlick, Anna; Osman, Iman; Polsky, David. Sensitivity of plasma BRAF and NRAS cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression. Molecular oncology. 2015 Sep 25;10(1):157-165 (1794612)

De novo versus nevus-associated melanomas: Differences in associations with prognostic indicators and survival.
Cymerman, Rachel M; Wang, Kun; Murzaku, Era C; Penn, Lauren A; Osman, Iman; Shao, Yongzhao; Polsky, David. De novo versus nevus-associated melanomas: Differences in associations with prognostic indicators and survival. [Meeting Abstract]. Journal of clinical oncology. 2015 MAY 20;33(15):?-? (1729522)